Semiconductors Healthcare Sector

Prime Medicine

Market Cap: US$154.7m

A biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States.

enGene Holdings

Market Cap: US$154.0m

Through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer.

Joint

Market Cap: US$152.7m

Operates and franchises chiropractic clinics in the United States.

AC Immune

Market Cap: US$151.4m

A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.

Longduoduo

Market Cap: US$149.8m

Together its subsidiaries, provides preventive healthcare solutions in the People’s Republic of China.

EKF Diagnostics Holdings

Market Cap: UK£112.4m

Engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally.

Tonix Pharmaceuticals Holding

Market Cap: US$148.6m

A biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease.

TerrAscend

Market Cap: CA$207.2m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Diaceutics

Market Cap: UK£110.7m

A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.

EUDA Health Holdings

Market Cap: US$146.4m

Operates as a healthcare specialty company.

4D Molecular Therapeutics

Market Cap: US$145.0m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

Vireo Growth

Market Cap: CA$202.0m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.

Esperion Therapeutics

Market Cap: US$144.7m

A pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.

Puma Biotechnology

Market Cap: US$144.0m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

Pro-Dex

Market Cap: US$141.3m

Designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide.

Panamera Holdings

Market Cap: US$141.1m

Does not have significant operations.

Global Cord Blood

Market Cap: US$140.6m

Provides umbilical cord blood storage and ancillary services in the People's Republic of China.

Tango Therapeutics

Market Cap: US$139.3m

A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.

Cogstate

Market Cap: AU$216.9m

A neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research.

KORU Medical Systems

Market Cap: US$138.9m

Develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.

DocGo

Market Cap: US$138.7m

Provides mobile health and medical transportation services in the United States and the United Kingdom.

NeOnc Technologies Holdings

Market Cap: US$138.5m

A clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies.

Journey Medical

Market Cap: US$137.9m

Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

CVRx

Market Cap: US$137.9m

A commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally.

SELLAS Life Sciences Group

Market Cap: US$137.2m

A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.

Eupraxia Pharmaceuticals

Market Cap: CA$189.6m

A clinical-stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector.

BioAge Labs

Market Cap: US$134.8m

A biopharmaceutical company that develops therapeutic product candidates for metabolic diseases.

Cybin

Market Cap: US$134.2m

A clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.

Nektar Therapeutics

Market Cap: US$133.1m

A biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally.

Atossa Therapeutics

Market Cap: US$133.0m

Operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States.

Nkarta

Market Cap: US$132.7m

A clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment.

Korro Bio

Market Cap: US$132.5m

A biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States.

Lucid Diagnostics

Market Cap: US$132.4m

Operates as a commercial-stage medical diagnostics technology company in the United States.

Oneview Healthcare

Market Cap: AU$205.1m

Develops and sells software services for the healthcare sector in Ireland, the United States, Australia, Ireland, the Middle East, and Asia.

Pulmonx

Market Cap: US$131.2m

A commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease.

Protalix BioTherapeutics

Market Cap: US$130.3m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.